Tag: SpineGuard
SpineGuard takes a significant step in its regulatory plan to strengthen its PediGuard® offering in China – 03/05/2024 at 6:00 p.m.
– Submission of a file to the Chinese authorities (“NMPA”) to obtain renewed approval of the PediGuard range currently available in China, as well as its extension to the PediGuard…
SpineGuard reaches milestone of 100,000 secure surgeries with its technology
(AOF) – SpineGuard announced that it had reached the milestone of 100,000 safe surgeries with its technology and 30 scientific publications. The medtech specialist in real-time surgical guidance (DSG) to…
Spineguard: 3.9 million euros in cash, visibility until 2025 – 01/10/2024 at 6:25 p.m.
(AOF) – Spineguard announces that its consolidated turnover is down 30% in the fourth quarter of 2023 compared to the fourth quarter of 2022 at 1.10 million euros, and by…
Spineguard: 3.9 million euros in cash, visibility until 2025
(AOF) – Spineguard announces that its consolidated turnover is down 30% in the fourth quarter of 2023 compared to the fourth quarter of 2022 at 1.10 million euros, and by…
SpineGuard announces its 2024 financial agenda – 12/20/2023 at 6:00 p.m.
PARIS, and BOULDER (Colorado, United States), December 20, 2023 -6:00 p.m. CET – SpineGuard (FR0011464452 – ALSGD, PEA-PME eligible), innovative company which deploys its digital real-time surgical guidance (DSG) technology…
SpineGuard announces its revenue for the 3rd quarter of 2023 – 10/11/2023 at 6:00 p.m.
PARIS, BOULDER (Colorado-United States), October 11, 2023 at 6:00 p.m. CEST – SpineGuard (FR0011464452 – ALSGD, PEA-PME eligible), innovative company which designs, develops and markets medical devices intended to secure…
SpineGuard publishes its results for the first half of 2023 – 09/12/2023 at 6:15 p.m.
PARIS (France) and BOULDER (Colorado, United States), September 12, 2023 – 6:15 p.m. (CEST) – SpineGuard (FR0011464452–ALSGD), innovative company deploying its digital real-time surgical guidance (DSG®) technology to secure and…
Spineguard: 4.58 million in cash, visibility “beyond 2025” – 09/12/2023 at 6:27 p.m.
(AOF) – Spineguard announces that its cash flow as of June 30, 2023 amounts to 4.58 million euros compared to 4.11 million as of December 31, 2022. In view of…
SpineGuard strengthens its intellectual property by obtaining a new patent in Brazil – 09/05/2023 at 18:30
– Protection of the essential “real time” character of the DSG technology PARIS, BOULDER (Colorado-United States), September 5, 2023 – 6:30 p.m. CEST – SpineGuard (FR0011464452 – ALSGD, PEA-PME eligible),…
SpineGuard: XinRong Medical has placed an order
By Arnaud Bives Published on 07/13/2023 at 08:54 (Boursier.com) — SpineGuard and XinRong Medical Group, one of…
SpineGuard announces its revenue for the first half of 2023 – 07/11/2023 at 18:00
For any questions on the voting procedures, you can contact the Investor Relations team by e-mail: [email protected]. PARIS, BOULDER (Colorado-United States), July 11, 2023 at 6:00 p.m. CEST – SpineGuard…
SpineGuard extends its treasury until the end of 2026
By Alexandra Saintpierre Published on 05/31/2023 at 6:46 p.m. Photo credit © Spineguard (Boursier.com) — SpineGuard sets up…